Stian Knappskog
Stian Knappskog
Verified email at med.uib.no
Title
Cited by
Cited by
Year
Signatures of mutational processes in human cancer
LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ...
Nature 500 (7463), 415-421, 2013
70652013
Signatures of mutational processes in human cancer
LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ...
Nature 500 (7463), 415-421, 2013
70652013
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ...
Nature 534 (7605), 47-54, 2016
14572016
Subclonal diversification of primary breast cancer revealed by multiregion sequencing
LR Yates, M Gerstung, S Knappskog, C Desmedt, G Gundem, P Van Loo, ...
Nature medicine 21 (7), 751-759, 2015
6142015
Genomic evolution of breast cancer metastasis and relapse
LR Yates, S Knappskog, D Wedge, JHR Farmery, S Gonzalez, ...
Cancer cell 32 (2), 169-184. e7, 2017
3972017
Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track–letter
A Torsvik, GV Røsland, A Svendsen, A Molven, H Immervoll, ...
Cancer research 70 (15), 6393-6396, 2010
3372010
Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes
JMC Tubio, Y Li, YS Ju, I Martincorena, SL Cooke, M Tojo, G Gundem, ...
Science 345 (6196), 1251343, 2014
3182014
Clinical effect of temozolomide‐based chemotherapy in poorly differentiated endocrine carcinoma after progression on first‐line chemotherapy
S Welin, H Sorbye, S Sebjornsen, S Knappskog, C Busch, K Öberg
Cancer 117 (20), 4617-4622, 2011
2682011
Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer
S Nik-Zainal, DC Wedge, LB Alexandrov, M Petljak, AP Butler, N Bolli, ...
Nature genetics 46 (5), 487-491, 2014
2532014
Gene expression profiling–based identification of molecular subtypes in stage IV melanomas with different clinical outcome
G Jönsson, C Busch, S Knappskog, J Geisler, H Miletic, M Ringnér, ...
Clinical cancer research 16 (13), 3356-3367, 2010
2322010
Somatic mutations reveal asymmetric cellular dynamics in the early human embryo
YS Ju, I Martincorena, M Gerstung, M Petljak, LB Alexandrov, R Rahbari, ...
Nature 543 (7647), 714-718, 2017
1892017
Australian Pancreatic Cancer Genome I
LB Alexandrov, S Nik-Zainal, DC Wedge, SA Aparicio, S Behjati, ...
Consortium IBC, Consortium IM-S, PedBrain I, Zucman-Rossi J, Futreal PA …, 2013
1822013
The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians
S Knappskog, M Bjørnslett, LM Myklebust, PEA Huijts, MP Vreeswijk, ...
Cancer cell 19 (2), 273-282, 2011
1152011
The level of synthesis and secretion of Gaussia princeps luciferase in transfected CHO cells is heavily dependent on the choice of signal peptide
S Knappskog, H Ravneberg, C Gjerdrum, C Tröβe, B Stern, IF Pryme
Journal of biotechnology 128 (4), 705-715, 2007
1052007
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration
M Smid, FG Rodríguez-González, AM Sieuwerts, R Salgado, ...
Nature communications 7 (1), 1-9, 2016
862016
CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer
R Chrisanthar, S Knappskog, E Løkkevik, G Anker, B Østenstad, ...
PLoS One 3 (8), e3062, 2008
832008
CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer
R Chrisanthar, S Knappskog, E Løkkevik, G Anker, B Østenstad, ...
PLoS One 3 (8), e3062, 2008
832008
CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer
R Chrisanthar, S Knappskog, E Løkkevik, G Anker, B Østenstad, ...
PLoS One 3 (8), e3062, 2008
832008
Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia
E McCormack, I Haaland, G Venås, RB Forthun, S Huseby, G Gausdal, ...
Leukemia 26 (5), 910-917, 2012
812012
Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases
IM Løes, H Immervoll, H Sorbye, JH Angelsen, A Horn, S Knappskog, ...
International journal of cancer 139 (3), 647-656, 2016
732016
The system can't perform the operation now. Try again later.
Articles 1–20